-
Genentech asking FDA for accelerated approval for drug to treat early-stage HER-2 breast cancer
Madely Health Headlines Commentary for September 11, 2013 [display_podcast] Source: FDA backs accelerated approval for drug to treat early-stage breast cancer CORRECTION: In the interview I state that the drug is not approved for use. It is indeed approved for the treatment of late-stage aggressive HER-2 breast cancer.
-
Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study
Madely Health Headlines Commentary for October 3, 2012 [display_podcast] Source: Breast cancer treatment targets tumours with few side effects Reference: Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
-
More information needed about woman's breast cancer before slamming Ontario Government for not covering breast-cancer drug
Madely Health Headlines Commentary for March 9, 2011 [display_podcast] Source: Ontario Health Minister won’t help mom get breast-cancer drug
-
Drug combo boosts advanced HER-2 breast cancer survival
Madely Health Headlines Commentary for December 14, 2009 Source: Drug Combo boosts advanced breast cancer survival Comment: This approach to treatment applies only to HER-2 breast cancers that according to the article represents 1 in 4 breast cancers.